Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis
Periostin can be a useful biomarker to stratify type 2-dominant UC patients, thereby predicting the efficacy of oral prednisolone. Moreover, periostin plays an important role in the setting of type 2-dominant UC.
Authors
- Satoshi Nunomura (ORCID: https://orcid.org/0000-0002-9315-4185)
- Kanako Yokomizo
- Yasuhisa Sakata (ORCID: https://orcid.org/0000-0002-5345-3770)
- Simon J. Conway (ORCID: https://orcid.org/0000-0001-5593-9259)
- Kenji Izuhara (ORCID: https://orcid.org/0000-0002-6983-907X)
- Yasuhiro Nanri (ORCID: https://orcid.org/0000-0002-4454-6553)
- Nanae Tsuruoka (ORCID: https://orcid.org/0000-0002-5152-5697)
- Hironobu Takedomi (ORCID: https://orcid.org/0000-0003-3284-0613)
- Motohiro Esaki (ORCID: https://orcid.org/0000-0002-1195-0074)
- Yuko Honda
- Takashi Akutagawa (ORCID: https://orcid.org/0000-0002-5616-3867)
- Shinichi Aishima (ORCID: https://orcid.org/0000-0002-7319-8623)
- Atsushi Kawaguchi (ORCID: https://orcid.org/0000-0002-8911-3321)
Institutions
- Kyushu University (JP)
- Saga University (JP)
- Saga Medical School Hospital (JP)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Inflammatory Bowel Diseases
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1093/ibd/izaf009
- Citations
- 2
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.59